GB201519606D0 - Anti-nerve growth factor antibodies and methods of preparing and using the same - Google Patents

Anti-nerve growth factor antibodies and methods of preparing and using the same

Info

Publication number
GB201519606D0
GB201519606D0 GBGB1519606.6A GB201519606A GB201519606D0 GB 201519606 D0 GB201519606 D0 GB 201519606D0 GB 201519606 A GB201519606 A GB 201519606A GB 201519606 D0 GB201519606 D0 GB 201519606D0
Authority
GB
United Kingdom
Prior art keywords
preparing
methods
same
growth factor
nerve growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1519606.6A
Other versions
GB2528811A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NVIP Pty Ltd
Original Assignee
NVIP Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NVIP Pty Ltd filed Critical NVIP Pty Ltd
Priority claimed from GB1320050.6A external-priority patent/GB2504888B/en
Publication of GB201519606D0 publication Critical patent/GB201519606D0/en
Publication of GB2528811A publication Critical patent/GB2528811A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/467—Igs with modifications in the FR-residues only
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB1519606.6A 2011-05-06 2012-05-08 Anti-nerve growth factor antibodies and methods of preparing and using the same Withdrawn GB2528811A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161483481P 2011-05-06 2011-05-06
US201161531439P 2011-09-06 2011-09-06
GB1320050.6A GB2504888B (en) 2011-05-06 2012-05-08 Anti-Nerve growth factor antibodies and methods of preparing and using the same

Publications (2)

Publication Number Publication Date
GB201519606D0 true GB201519606D0 (en) 2015-12-23
GB2528811A GB2528811A (en) 2016-02-03

Family

ID=55071746

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1519606.6A Withdrawn GB2528811A (en) 2011-05-06 2012-05-08 Anti-nerve growth factor antibodies and methods of preparing and using the same

Country Status (1)

Country Link
GB (1) GB2528811A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022268937A1 (en) * 2021-05-05 2023-10-26 Trianni, Inc. Transgenic rodents expressing chimeric equine-rodent antibodies and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030601A1 (en) * 2003-12-24 2005-06-25 Lay Line Genomics Spa METHOD FOR THE HUMANIZATION OF HUMANIZED ANTIBODIES AND ANTIBODIES WITH IT OBTAINED.

Also Published As

Publication number Publication date
GB2528811A (en) 2016-02-03

Similar Documents

Publication Publication Date Title
GB2504887B (en) Anti-Nerve growth factor antibodies and methods of preparing and using the same
SG10201500960TA (en) Anti-nerve growth factor antibodies and methods of preparing and using the same
GB201517547D0 (en) Anti-nerve growth factor antibodies and methods of preparing and using the same
GB2504888B (en) Anti-Nerve growth factor antibodies and methods of preparing and using the same
HK1255608A1 (en) Anti-htra1 antibodies and methods of use
HK1213581A1 (en) Anti-cd40 antibodies and methods of use -cd40
HK1212256A1 (en) Anti-mcam antibodies and associated methods of use -mcam
ZA201308022B (en) Anti-cd40 antibodies and methods of use
EP2748199A4 (en) Anti-ox40 antibodies and methods of using the same
ZA201403760B (en) Anti-cd98 antibodies and methods of use thereof
HK1201843A1 (en) Anti-polyubiquitin antibodies and methods of use
GB201223276D0 (en) Antibodies and methods of producing same
ZA201306451B (en) Anti-il-6 receptor antibodies and methods of use
EP2771694A4 (en) Monoclonal antibodies and methods of use
EP2611832A4 (en) Anti-cxcl13 antibodies and methods of using the same
EP2663330A4 (en) Anti-tlr4 antibodies and methods of use thereof
EP2755667A4 (en) Method for enhancing the growth and fullness of hair
HK1199735A1 (en) Caninised tumour necrosis factor antibodies and methods of using the same
SG11201400405TA (en) Caninised antibodies and method for the production of same
HUS2200012I1 (en) Anti-nerve growth factor antibodies and methods of preparing and using the same
GB201519606D0 (en) Anti-nerve growth factor antibodies and methods of preparing and using the same
GB2505352B (en) Anti-nerve growth factor antibodies and methods of preparing and using the same

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)